secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2022-02-24T23:59:59+00:00
Accession:  0001171843-22-001324
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Joint Corp. Q4 revenue $22.4M (+32% YoY); net income $224K; guides FY22 rev $102-106M
--------------------------------------------------------------------------------

- Full-year 2021 revenue $81.2M (+38% YoY); system-wide sales $361.1M (+39%).
- Net income $7.2M for 2021 vs. $13.2M in 2020; Adjusted EBITDA $13.3M vs. $9.1M.
- Opened 130 clinics in 2021 (110 franchised, 20 greenfield); total 706 clinics at year-end.
- Q4 net income $224K ($0.01 diluted EPS) vs. $10.6M ($0.72) in Q4 2020, which included $8.9M tax benefit.
- Guides 2022 revenue $102-106M, Adjusted EBITDA $15-17M, and 160-180 total new clinics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000117184322001324/0001171843-22-001324-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000117184322001324/f8k_022422.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-001324

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer